ArticleJournal of clinical medicine2026

Unintended Interruption of Caplacizumab Therapy Can Compromise Outcomes in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Lessons from Two Clinical Cases.

Fedai Özcan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.